Departments convene to improve anaphylaxis care in schools

By Whitney Blake August 17, 2026
Departments convene to improve anaphylaxis care in schools - anaphylaxis care
Departments convene to improve anaphylaxis care in schools

Government departments met in May to discuss how anaphylaxis is prevented and treated in Ireland’s early‑learning, childcare and school environments, a step prompted by concerns raised last year by the Health Service Executive’s Child Health Public Health unit.

Inter‑departmental talks bring health, education and child services together

The gathering brought together the Department of Children, Disability and Equality (DCDE), the Department of Health (DoH) and the Department of Education and Youth. A DCDE spokesperson said the “matter remains under discussion at this time.” The health department added that “stakeholders will engage further to discuss any potential next steps,” indicating that policy development is still in an exploratory phase.

These ministries are responding to a paper titled Anaphylaxis in childcare and educational settings in Ireland – an overview of issues and concerns from a child health perspective. Authored by Dr Abigail Collins, Clinical Lead for Child Health Public Health, and her colleagues, the document was circulated to relevant departments last year. It highlighted gaps in current practice and called for a national policy covering prevention, recognition and emergency response.

Legal ambiguity and training gaps are chief obstacles

The HSE report warned that legal uncertainty may stop staff from using adrenaline auto‑injectors promptly when a child shows signs of anaphylaxis. It argued that children must be “protected from preventable death” and that staff should be “protected and obligated” to administer or assist with an auto‑injector. Clear legal guidance is needed so employees can confirm they are “permitted and protected” when acting in suspected cases.

Related: What are the most important benefits  of going for prenatal yoga for ladies?

Current legislation, specifically statutory instrument (SI) No 449/2015, permits organisations to procure emergency medicines such as adrenaline, provided the recipient has a prior prescription or diagnosis and that the information is reasonably obtainable. Registration under this instrument remains low, and the Pre‑Hospital Emergency Care Council has said it “would support” a review of the framework.

Beyond legal clarity, the document calls for mandatory training on anaphylaxis awareness and emergency response for all staff, as well as the placement of wall‑mounted auto‑injectors, even for children presenting with anaphylaxis for the first time.

Why the focus matters for schools and childcare centres

Most anaphylactic reactions are not fatal, yet symptoms can rise quickly and delayed treatment raises the risk of death. In practice, a child’s ability to participate fully and safely in school or childcare activities hinges on whether staff feel confident and authorized to act.

In England, statutory measures for anaphylaxis prevention in schools are set to begin in September, offering a comparative benchmark for Irish policymakers. While Ireland’s legal framework already allows certain emergency medicines, the low uptake suggests practical barriers remain.

One practical issue is the availability of auto‑injectors in settings where a child might first experience a reaction. Without dedicated devices, staff may need to locate a child’s personal prescription, which can waste precious minutes. Providing wall‑mounted units could streamline response, but it also raises questions about storage, maintenance and training.

Related: Aston Martin DB12 S sets new standard

From a broader perspective, the push for clearer policy reflects a growing recognition that schools and childcare centres are not just educational sites but also places where health emergencies can occur. Ensuring that staff are legally protected and adequately equipped aligns with wider public‑health goals of reducing preventable injuries among children.

Next steps and stakeholder involvement

Both the DCDE and DoH have indicated that further consultations with stakeholders—including school boards, parent groups and health professionals—are planned. The aim is to refine recommendations and potentially amend the existing statutory instrument to boost registration and compliance.

While the meeting in May did not produce a final policy, it marks a coordinated effort across ministries to address a gap that has been highlighted by clinicians and families alike. Continued dialogue will be essential to translate the recommendations into actionable guidelines that protect children and support staff.

Children’s safety remains the priority.